GlassScriptPhysician profile
Suman Radhakrishna
NPI 1225069248
$4,685.53
in general payments reported to CMS, 2019-2025
16 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $341 · 2021: $72.29 · 2022: $144 · 2023: $118 · 2024: $2,259 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $1,039 · Consulting Fee: $988 · Education: $1.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $1,039.02 |
| Consulting Fee | $987.50 |
| Education | $1.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,036.34 | 2024 | |
| Shionogi INC | $1,333.79 | 2020-2025 | S-217622, Fetroja |
| Merck Sharp & Dohme LLC | $240.41 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Allergan, INC. | $185.13 | 2019-2020 | |
| Insmed, INC. | $141.24 | 2019-2021 | |
| Abbott Laboratories | $135.77 | 2019 | |
| Paratek Pharmaceuticals, INC. | $112.50 | 2020 | |
| Comsort, INC | $100.00 | 2019 | |
| Abbvie INC. | $93.25 | 2021-2022 | |
| Melinta Therapeutics, LLC | $79.80 | 2024 | Rezzayo |
| Janssen Products, LP | $54.99 | 2020 | |
| Viiv Healthcare Company | $41.36 | 2019 | |
| Janssen Biotech, INC. | $40.96 | 2020 | |
| Biofire Diagnostics, LLC | $40.00 | 2020 | |
| Chiesi USA, INC. | $33.63 | 2023 | Curosurf |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suman Radhakrishna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.